Editors’ Note: After several decades in the U.S., renowned researcher Jacques Grosset M.D., professor, Center for Tuberculosis Research at Johns Hopkins Medicine, is retiring and returning to his native France. Earlier this year, at the invitation of his friend, Einstein’s William Jacobs, Jr., Ph.D., professor of microbiology & immunology and HHMI investigator, Dr. Grosset spoke at Read More
This raises an important question: When the FDA and similar agencies make decisions on public health issues that are intertwined with science, do the larger scientific and medical communities wield any influence?
The field of medicine is littered with eponyms that celebrate physicians who first described syndromes, signs, surgical procedures and anatomic structures. Though we use these eponyms every day, we rarely take the time to consider the lives of the people behind the names. Recently, while evaluating a five-year-old named Ben, I was forced to stop Read More
Editors' Note: The following blog post first appeared on Forbes.com. In his seventh and last State of the Union address on January 12th, President Barack Obama announced a “moonshot” with the goal of making “America the country that cures cancer once and for all.” The “moonshot” program is to be led by Vice President Joe Read More
Tuberculosis (TB) is an ancient disease that has afflicted humans since the dawn of civilization and remains very much with us even now. In fact, more people will probably die from TB in 2016 than from any other single infectious disease, with HIV a close second. This grim fact is well documented by annual reports Read More
Editors’ Note: February 29 marks the ninth annual Rare Disease Day, a worldwide event devoted to raising awareness of more than 6,500 rare diseases, of which less than 5 percent have any available treatment. We spoke with Dr. Steven Walkley, director of the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center and professor in Read More